Affiliation:
1. *Pelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, OH
2. †Department of Otolaryngology, The Ohio State University, Columbus, OH
3. ‡Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH
4. §Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH
Abstract
This Pillars of Immunology article is a commentary on “PD-L2 is a second ligand for PD-1 and inhibits T cell activation,” a pivotal article written by Y. Latchman, C. R. Wood, T. Chernova, D. Chaudhary, M. Borde, I. Chernova, Y. Iwai, A. J. Long, J. A. Brown, R. Nunes, E. A. Greenfield, K. Bourque, V. A. Boussiotis, L. L. Carter, B. M. Carreno, N. Malenkovich, H. Nishimura, T. Okazaki, T. Honjo, A. H. Sharpe, and G. J. Freeman, and published in Nature Immunology, in 2001. https://www.nature.com/articles/ni0301_261.
Publisher
The American Association of Immunologists
Subject
Immunology,Immunology and Allergy